MetaCap

Optimi Health (OPTH) vs SCYNEXIS (SCYX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

SCYNEXIS is the larger company by market cap ($42.0 million vs $23.4 million), about 1.8 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

OPTH-32.81%SCYX-21.03%
+12%-12%-36%
May 20, 20261 yearOct 8, 2026
OPTH-30.17%SCYX-27.84%
+4%-17%-38%
May 18, 20265 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

OPTH versus SCYX key metrics
MetricOPTHSCYX
Share price$4.09$4.22
Market cap$23.39M$41.99M
1-day change0.00%-11.72%
YTD return—-16.53%
1-year return—-32.11%
5-year return—-90.53%
EPS (TTM)$-1.56$-0.89
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$6.40$9.12
52-week low$4.00$3.53
Distance from 52-week high-36.17%-53.73%
Analyst consensus—strong_buy
Avg. price target upside—+760.90%
Average volume45.47K279.10K
Shares outstanding5.73M9.95M
Employees—18
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Optimi Health

OPTH stock →

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada.

Health Care · Biotechnology: Pharmaceutical Preparations

About SCYNEXIS

SCYX stock →

SCYNEXIS, Inc., a biotechnology company, engages in drug development for the treatment and prevention of difficult-to-treat and drug-resistant fungal infections in the United States. The company offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis and for the reduction in the incidence of recurrence.

Health Care · Biotechnology: Pharmaceutical Preparations · 18 employees

OPTH vs SCYX FAQ

Which is bigger, Optimi Health or SCYNEXIS?

SCYNEXIS (SCYX) is larger, with a market capitalization of $41.99M compared with $23.39M for Optimi Health (OPTH).

Are Optimi Health and SCYNEXIS in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons